Intellipharmaceutics International Inc. (I.TO) reported a second-quarter net loss of $1.4 million or $0.08 per share, narrower than the net loss of $2.0 million or $0.12 per share in the comparable quarter last year.
The company attributed the narrower loss to a reduction in the fair value adjustment of derivative liability of $0.8 million and the timing of certain research and development activities.
For comments and feedback: editorial@rttnews.com